Molecular Medicine

The researchers that make up the division of Molecular Medicine provide cutting-edge translational research to bridge the gap between bench work and clinical care.  

An academic unit of the Department of Internal Medicine, work through the University of New Mexico Comprehensive Cancer Center. We are located at the Cancer Research Facility.  

Our mission is to continually:   

• Discover the molecular mechanisms of human disease 
• Develop new diagnostic, therapeutic, imaging and prevention targets for human disease 
• Elucidate mechanisms of action and resistance of novel agents 
• Evaluate promising targeted agents in pre-clinical models 
• Translate novel agents to early phase human clinical trials with UNM and industry partners  

About UNM Comprehensive Cancer Center  

The UNM CCC is the Official Cancer Center of New Mexico and the only National Cancer Institute-designated Cancer Center in a 500-mile radius. UNM CCC staffs more than 125 board-certified oncology physicians, forming New Mexico’s largest cancer care team.  

• Learn more about Molecular Medicine fellowships! 

Approximately 60% of adults and virtually all children in New Mexico diagnosed with cancer receive treatment at UNM CCC. Clinicians provide more than 135,000 clinic visits each year. Through a partnership with the New Mexico Cancer Care Alliance, the UNM CCC offers access to more than 175 clinical trials to New Mexicans in every part of the state.  

Annual research funding of almost $60 million supports the UNM CCC’s 130 cancer scientists. Working with partners at Los Alamos and Sandia National Laboratories, Lovelace Respiratory Research Institute, and New Mexico State University, they have developed new diagnostics and drugs for leukemia, melanoma and cancers of the brain, breast, ovaries, prostate, liver and pancreas. Learn more.